http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2390015

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't
endingPage 227
issn 1542-6270
1060-0280
issueIdentifier 2
pageRange 220-227
publicationName The Annals of pharmacotherapy
startingPage 220
bibliographicCitation Crandon JL, Kuti JL, Jones RN, Nicolau DP. Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance. Ann Pharmacother. 2009 Feb;43(2):220–7. doi: 10.1345/aph.1l473. PMID: 19193582.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b8e659a199150e434c9160b3bd6c102
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e30759aa5f71d32e99706a18adc001a0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9881237dc7b0e054248184c22580db7a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_034ecf0e47425a67bce0142b3dfc4dbd
date 200902
identifier https://doi.org/10.1345/aph.1l473
https://pubmed.ncbi.nlm.nih.gov/19193582
isPartOf https://portal.issn.org/resource/ISSN/1060-0280
https://portal.issn.org/resource/ISSN/1542-6270
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1999
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Comparison of 2002–2006 OPTAMA Programs for US Hospitals: Focus on Gram-Negative Resistance
discusses http://id.nlm.nih.gov/mesh/M0001329
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008826Q000639
http://id.nlm.nih.gov/mesh/D000890Q000008
http://id.nlm.nih.gov/mesh/D007362Q000639
http://id.nlm.nih.gov/mesh/D000890Q000493
http://id.nlm.nih.gov/mesh/D006090Q000187
http://id.nlm.nih.gov/mesh/D004352
hasSubjectTerm http://id.nlm.nih.gov/mesh/D014481
http://id.nlm.nih.gov/mesh/D009010
http://id.nlm.nih.gov/mesh/D015233
http://id.nlm.nih.gov/mesh/D000890Q000627
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54686904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16726873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45114137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5479537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46173365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5479530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5491295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5484131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9570985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23724843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44298077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23679441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66509024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133687818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121225277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150610

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127998401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128850235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248087834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247768374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129948482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135739496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127755594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128667128

Total number of triples: 69.